USMLE Step 1 & 2 Antibiotics and Antivirals
Last updated: May 2, 2026
Antibiotics and Antivirals questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
On Step 1 and Step 2 CK, antimicrobial questions almost always reduce to three linked decisions: identify the drug class by mechanism (cell wall, protein synthesis 30S vs 50S, DNA/folate, RNA polymerase, viral polymerase/protease), match that class to its spectrum (gram-positive, gram-negative, atypicals, anaerobes, MRSA, Pseudomonas, HSV, HIV, HCV, influenza), and recognize its signature toxicity or resistance mechanism. The exam writers build distractors by swapping one of these three axes — same mechanism but wrong spectrum, right spectrum but wrong toxicity, or right drug class but wrong target subunit. Master the canonical pairings and you will collapse most antimicrobial vignettes into a 30-second pattern match.
Elements breakdown
Cell wall inhibitors
Drugs that disrupt peptidoglycan synthesis, leading to bacterial lysis.
- Beta-lactams bind PBPs and block transpeptidation
- Vancomycin binds D-Ala-D-Ala terminus
- Bactericidal; require actively dividing organisms
- Resistance via beta-lactamase or altered PBP (MRSA mecA)
Common examples:
- Penicillin G, ampicillin, piperacillin-tazobactam
- Cefazolin, ceftriaxone, cefepime, ceftaroline
- Meropenem, aztreonam, vancomycin
30S protein synthesis inhibitors
Bind the 30S ribosomal subunit; block initiation or cause misreading.
- Aminoglycosides: misread mRNA, bactericidal
- Tetracyclines: block tRNA binding, bacteriostatic
- Aminoglycosides need O2 (inactive vs anaerobes)
- Tetracyclines chelate divalent cations
Common examples:
- Gentamicin, tobramycin, amikacin
- Doxycycline, minocycline, tigecycline
50S protein synthesis inhibitors
Bind the 50S subunit; block peptidyl transferase or translocation.
- Macrolides block translocation
- Clindamycin blocks peptidyl transferase
- Linezolid blocks initiation complex
- Chloramphenicol blocks peptide bond formation
Common examples:
- Azithromycin, clarithromycin, erythromycin
- Clindamycin, linezolid, chloramphenicol
DNA/folate/RNA inhibitors
Target nucleic acid synthesis or transcription.
- Fluoroquinolones inhibit topoisomerase II/IV
- TMP-SMX blocks sequential folate synthesis steps
- Metronidazole forms toxic radicals in anaerobes
- Rifampin inhibits bacterial DNA-dependent RNA polymerase
Common examples:
- Ciprofloxacin, levofloxacin, moxifloxacin
- TMP-SMX, metronidazole, rifampin
Antiviral nucleoside analogs
Phosphorylated to active form; chain-terminate viral DNA/RNA polymerase.
- Acyclovir requires HSV/VZV thymidine kinase
- Ganciclovir activated by CMV UL97 kinase
- Tenofovir/lamivudine inhibit HIV reverse transcriptase
- Sofosbuvir inhibits HCV NS5B polymerase
Common examples:
- Acyclovir, valacyclovir, ganciclovir, foscarnet
- Tenofovir, emtricitabine, sofosbuvir
Antiviral non-nucleoside agents
Block viral entry, uncoating, integration, protease, or neuraminidase.
- Oseltamivir inhibits influenza neuraminidase
- NNRTIs bind reverse transcriptase allosterically
- Protease inhibitors end in -navir
- Integrase inhibitors end in -tegravir
Common examples:
- Oseltamivir, baloxavir
- Efavirenz, dolutegravir, ritonavir-boosted darunavir
Common patterns and traps
The Subunit Swap
The vignette describes a clinical scenario where the correct drug class is obvious from spectrum, but the question asks about mechanism. Distractors include another antibiotic with the right spectrum but wrong ribosomal subunit, or right subunit but wrong drug. The trap rewards rote spectrum knowledge while punishing fuzzy mechanism recall.
"Inhibits the 30S ribosomal subunit" appearing as a wrong answer when the correct drug actually binds 50S, or vice versa.
The Spectrum Mismatch
A pathogen-mechanism distractor lists a drug whose mechanism is correctly described but whose spectrum doesn't cover the organism in the vignette. Common version: aminoglycoside offered for an anaerobic infection, or vancomycin offered for a gram-negative.
"Gentamicin" listed for a Bacteroides abscess, or "vancomycin" for E. coli pyelonephritis.
The Toxicity Trap
The stem describes a textbook adverse effect (red man syndrome, tendon rupture, ototoxicity, gray baby syndrome, peripheral neuropathy) and asks which drug caused it. Distractors are drugs with overlapping spectrum but different signature toxicities, rewarding tight pairings of drug-to-side-effect.
A patient on vancomycin develops flushing during infusion; distractors include daptomycin, linezolid, and ceftaroline — all anti-MRSA but with different toxicities.
The Activation Requirement
Antiviral nucleoside analogs require viral kinase activation. The trap offers a drug active against the wrong herpesvirus because the candidate forgets that acyclovir needs HSV/VZV thymidine kinase and does nothing for CMV, which encodes UL97 instead.
A post-transplant patient with CMV retinitis, with "acyclovir" offered as a distractor next to ganciclovir or foscarnet.
The Resistance Mechanism Tell
The vignette plants a resistance clue ("altered PBP2a," "D-Ala-D-Lac terminus," "plasmid-encoded beta-lactamase," "M184V mutation") that uniquely identifies the failed or required drug class. Spotting the molecular tell short-circuits the differential.
A nosocomial isolate described as having "D-Ala-D-Lac peptidoglycan terminus" — that's vancomycin-resistant Enterococcus, and vancomycin is the wrong answer.
How it works
Imagine a 62-year-old with community-acquired pneumonia who develops a cough that won't resolve and a chest x-ray showing patchy interstitial infiltrates; sputum gram stain is unrevealing, and you need atypical coverage. You reach for azithromycin because macrolides cover Mycoplasma, Chlamydia, and Legionella by binding the 50S subunit and blocking translocation. The trap distractor will be clindamycin — also a 50S binder, also bacteriostatic, but its spectrum is anaerobes above the diaphragm and gram-positives, not atypicals. Another distractor will be doxycycline, which does cover atypicals but binds 30S, not 50S, so if the stem asks about mechanism the answer flips. Finally, gentamicin will tempt those who hear "pneumonia" and think gram-negatives, but aminoglycosides need oxygen, do not penetrate respiratory secretions well, and miss atypicals entirely. The lesson: mechanism, spectrum, and toxicity are three locks the exam writer turns independently — verify all three before committing.
Worked examples
Which of the following best describes the mechanism of action of the most appropriate first-line therapy for this patient's ocular condition?
- A Activated by viral thymidine kinase, then incorporated into viral DNA causing chain termination
- B Phosphorylated by viral UL97 kinase, then inhibits viral DNA polymerase as a guanosine analog ✓ Correct
- C Directly inhibits viral DNA polymerase as a pyrophosphate analog without requiring activation
- D Binds viral neuraminidase and prevents release of progeny virions from infected cells
Why B is correct: This is post-transplant CMV retinitis — the classic 'pizza pie' fundus with hemorrhages and exudates in an immunosuppressed patient. First-line therapy is ganciclovir (or its prodrug valganciclovir), which is phosphorylated by the CMV-encoded UL97 kinase to its active triphosphate form, then competes with dGTP at viral DNA polymerase to chain-terminate replication. The UL97-dependence explains why CMV (which has UL97) responds to ganciclovir while HSV-only-active drugs like acyclovir do not.
Why each wrong choice fails:
- A: This describes acyclovir, which requires HSV/VZV-encoded thymidine kinase for activation. CMV lacks thymidine kinase and uses UL97 instead, so acyclovir is essentially inactive against CMV retinitis. Candidates who lump all 'herpesviruses' together fall here. (The Activation Requirement)
- C: This describes foscarnet, which does inhibit CMV DNA polymerase and is correctly activation-independent — but it is second-line, reserved for ganciclovir-resistant CMV or patients with severe ganciclovir-induced neutropenia. As first-line therapy in a previously untreated patient, ganciclovir wins. (The Spectrum Mismatch)
- D: This describes oseltamivir, an influenza neuraminidase inhibitor with no activity against herpesviruses at all. Picking this means missing the entire CMV diagnosis and defaulting to a generic antiviral. (The Spectrum Mismatch)
Which of the following antibiotics, when used as monotherapy, would be most likely to retain activity against this organism by binding a target distinct from the altered penicillin-binding protein?
- A Cefazolin
- B Piperacillin-tazobactam
- C Vancomycin ✓ Correct
- D Aztreonam
Why C is correct: This is methicillin-resistant Staphylococcus aureus (MRSA): mecA encodes PBP2a, which has low affinity for all beta-lactams. Vancomycin bypasses this resistance entirely because it binds the D-Ala-D-Ala terminus of peptidoglycan precursors rather than PBPs, so altering PBP2a does not affect its target. Vancomycin remains a first-line agent for MRSA.
Why each wrong choice fails:
- A: Cefazolin is a first-generation cephalosporin and excellent against methicillin-susceptible S. aureus, but like all standard beta-lactams it binds PBPs and is defeated by PBP2a. Only ceftaroline among cephalosporins reliably covers MRSA. (The Resistance Mechanism Tell)
- B: The beta-lactamase inhibitor tazobactam protects piperacillin from beta-lactamase enzymes, but mecA-mediated resistance is not enzymatic — it is target alteration. Adding a beta-lactamase inhibitor does nothing when the PBP itself has changed. (The Resistance Mechanism Tell)
- D: Aztreonam is a monobactam with activity essentially limited to aerobic gram-negatives; it has no meaningful activity against gram-positive cocci including S. aureus, MRSA or otherwise. Wrong spectrum entirely. (The Spectrum Mismatch)
Which of the following is the most likely mechanism of action of the antibiotic that caused this patient's adverse effect?
- A Inhibition of bacterial dihydrofolate and dihydropteroate synthesis
- B Inhibition of DNA gyrase (topoisomerase II) and topoisomerase IV ✓ Correct
- C Inhibition of the 30S ribosomal subunit causing mRNA misreading
- D Inhibition of bacterial cell wall transpeptidation by binding penicillin-binding proteins
Why B is correct: Bilateral Achilles tendinopathy and tendon rupture are signature toxicities of fluoroquinolones (ciprofloxacin, levofloxacin), commonly used for uncomplicated cystitis when other agents are contraindicated. Their mechanism is inhibition of bacterial DNA gyrase (topoisomerase II) in gram-negatives and topoisomerase IV in gram-positives, preventing supercoil management during replication. The drug-toxicity-mechanism triad here is fluoroquinolone → tendon rupture → topoisomerase inhibition.
Why each wrong choice fails:
- A: This describes TMP-SMX, also a reasonable choice for uncomplicated cystitis. But TMP-SMX's signature toxicities are hyperkalemia, Stevens-Johnson syndrome, hemolysis in G6PD deficiency, and bone marrow suppression — not tendinopathy. Right indication, wrong toxicity profile. (The Toxicity Trap)
- C: This describes aminoglycosides like gentamicin. They are not used orally for uncomplicated cystitis (poor oral bioavailability), and their signature toxicities are nephrotoxicity and ototoxicity, not tendon rupture. Wrong mechanism for the toxicity described. (The Subunit Swap)
- D: This describes beta-lactams (e.g., amoxicillin, cephalexin), which can be used for cystitis. Beta-lactam toxicities are hypersensitivity, rash, and C. difficile colitis — tendon rupture is not on the list. The mechanism is correctly described but pinned to the wrong drug class. (The Toxicity Trap)
Memory aid
"Buy AT 30, CCEL at 50" — Aminoglycosides and Tetracyclines bind 30S; Chloramphenicol, Clindamycin, Erythromycin (macrolides), and Linezolid bind 50S. For antivirals: "-cyclovir" = herpes family, "-tegravir" = HIV integrase, "-navir" = HIV protease, "-buvir" = HCV polymerase.
Key distinction
Acyclovir vs ganciclovir: both are guanosine analogs and both chain-terminate viral DNA polymerase, but acyclovir is activated by HSV/VZV-encoded thymidine kinase and is essentially inactive against CMV (which lacks TK), while ganciclovir is phosphorylated by CMV's UL97 kinase. Pick acyclovir for HSV encephalitis or shingles; pick ganciclovir for CMV retinitis or post-transplant CMV.
Summary
Solve antimicrobial vignettes by locking down three axes — mechanism, spectrum, and signature toxicity — because every distractor swaps exactly one of them.
Practice antibiotics and antivirals adaptively
Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is antibiotics and antivirals on the USMLE Step 1 & 2?
On Step 1 and Step 2 CK, antimicrobial questions almost always reduce to three linked decisions: identify the drug class by mechanism (cell wall, protein synthesis 30S vs 50S, DNA/folate, RNA polymerase, viral polymerase/protease), match that class to its spectrum (gram-positive, gram-negative, atypicals, anaerobes, MRSA, Pseudomonas, HSV, HIV, HCV, influenza), and recognize its signature toxicity or resistance mechanism. The exam writers build distractors by swapping one of these three axes — same mechanism but wrong spectrum, right spectrum but wrong toxicity, or right drug class but wrong target subunit. Master the canonical pairings and you will collapse most antimicrobial vignettes into a 30-second pattern match.
How do I practice antibiotics and antivirals questions?
The fastest way to improve on antibiotics and antivirals is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for antibiotics and antivirals?
Acyclovir vs ganciclovir: both are guanosine analogs and both chain-terminate viral DNA polymerase, but acyclovir is activated by HSV/VZV-encoded thymidine kinase and is essentially inactive against CMV (which lacks TK), while ganciclovir is phosphorylated by CMV's UL97 kinase. Pick acyclovir for HSV encephalitis or shingles; pick ganciclovir for CMV retinitis or post-transplant CMV.
Is there a memory aid for antibiotics and antivirals questions?
"Buy AT 30, CCEL at 50" — Aminoglycosides and Tetracyclines bind 30S; Chloramphenicol, Clindamycin, Erythromycin (macrolides), and Linezolid bind 50S. For antivirals: "-cyclovir" = herpes family, "-tegravir" = HIV integrase, "-navir" = HIV protease, "-buvir" = HCV polymerase.
What's a common trap on antibiotics and antivirals questions?
Confusing 30S vs 50S binders when stem tests mechanism
What's a common trap on antibiotics and antivirals questions?
Picking a drug with right spectrum but wrong toxicity profile
Ready to drill these patterns?
Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more antibiotics and antivirals questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial